Abstract |
The sphingolipid ceramide is a pro apoptotic molecule of ceramide metabolic pathway and is hydrolyzed to proliferative metabolite, sphingosine 1 phosphate by the action of acid ceramidase. Being upregulated in the tumors of breast, acid ceramidase acts as a potential target for breast cancer therapy. We aimed at targeting this enzyme with a small molecule acid ceramidase inhibitor, Ceranib 2 in human breast cancer cell lines MCF 7 and MDA MB 231. Ceranib 2 effectively inhibited the growth of both the cell lines in dose and time dependant manner. Morphological apoptotic hallmarks such as chromatin condensation, fragmented chromatin were observed in AO/EtBr staining. Moreover, ladder pattern of fragmented DNA observed in DNA gel electrophoresis proved the apoptotic activity of Ceranib 2 in breast cancer cell lines. The apoptotic events were associated with significant increase in the expression of pro-apoptotic genes (Bad, Bax and Bid) and down regulation of anti-apoptotic gene (Bcl 2). Interestingly, increase in sub G1 population of cell cycle phase analysis and elevated Annexin V positive cells after Ceranib 2 treatment substantiated its apoptotic activity in MCF 7 and MDA MB 231 cell lines. Thus, we report Ceranib 2 as a potent therapeutic agent against both ER(+) and ER(-) breast cancer cell lines.
|
Authors | Helen Shiphrah Vethakanraj, Thabraz Ahmed Babu, Ganesh Babu Sudarsanan, Prabhu Kumar Duraisamy, Sekar Ashok Kumar |
Journal | Biochemical and biophysical research communications
(Biochem Biophys Res Commun)
Vol. 464
Issue 3
Pg. 833-9
(Aug 28 2015)
ISSN: 1090-2104 [Electronic] United States |
PMID | 26188095
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2015 Elsevier Inc. All rights reserved. |
Chemical References |
- 3-(3-(4-methoxyphenyl)acryloyl)-4-phenyl-1H-quinolin-2-one
- Antineoplastic Agents
- Ceramides
- Enzyme Inhibitors
- Quinolones
- Tamoxifen
- ASAH1 protein, human
- Acid Ceramidase
|
Topics |
- Acid Ceramidase
(antagonists & inhibitors)
- Antineoplastic Agents
(pharmacology)
- Apoptosis
(drug effects, genetics)
- Breast Neoplasms
(drug therapy, genetics, metabolism, pathology)
- Cell Cycle
(drug effects)
- Cell Survival
(drug effects)
- Ceramides
(metabolism)
- Enzyme Inhibitors
(pharmacology)
- Female
- Gene Expression Regulation, Neoplastic
(drug effects)
- Humans
- Inhibitory Concentration 50
- MCF-7 Cells
(drug effects)
- Metabolic Networks and Pathways
(drug effects)
- Molecular Targeted Therapy
- Quinolones
(pharmacology)
- Tamoxifen
(pharmacology)
|